Stock Events

Stock Events

AIxCrypto 

$0.9317
43
-$0.01-0.57% Tuesday 20:00
-$0.06-6.2%Tuesday 23:36After hours

Statistics

Day High
0.9366
Day Low
0.909
52W High
8.81
52W Low
0.593
Volume
5,040
Avg. Volume
-
Mkt Cap
18.85M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17NovExpected
Q1 2024
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-26
-17.6
-9.19
-0.79
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-19.53MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AIXC. It's not an investment recommendation.
Schwab US Dividend Equity
2
SCHD
Virgin Galactic
2
SPCE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap181.18B
Gilead Sciences is a biopharmaceutical company that competes in the development of therapeutics in areas similar to Qualigen, such as viral diseases, making it a direct competitor.
AMGEN
AMGN
Mkt Cap237.52B
Amgen is a biotech firm focusing on human therapeutics, including treatments for illnesses that Qualigen also targets, positioning it as a competitor.
Bristol-Myers Squibb
BMY
Mkt Cap136.88B
Bristol Myers Squibb operates in the biopharmaceutical field, developing prescription drugs that overlap with Qualigen's therapeutic areas.
Pfizer
PFE
Mkt Cap159.99B
Pfizer is a global pharmaceutical corporation with a broad product portfolio that includes treatments in areas competing with Qualigen's focus.
Merck
MRK
Mkt Cap376.37B
Merck & Co. is known for its innovative medicines and vaccines, some of which directly compete with Qualigen's product pipeline.
Abbvie
ABBV
Mkt Cap468.22B
AbbVie is a research-based biopharmaceutical company with a strong emphasis on developing innovative therapies, including those in competition with Qualigen.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.87B
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of medicines for serious conditions, competing with Qualigen's therapeutic areas.
Vertex Pharmaceuticals
VRTX
Mkt Cap138.91B
Vertex Pharmaceuticals is focused on creating new possibilities in medicine to cure diseases and improve people's lives, including areas where Qualigen operates.
Novartis
NVS
Mkt Cap301.95B
Novartis is a global healthcare company that provides solutions to address the evolving needs of patients worldwide, including in sectors where Qualigen is active.
Astrazeneca
AZN
Mkt Cap257.42B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of medical therapies that compete with Qualigen's developments.

About

AIxCrypto Holdings Inc is a technology infrastructure company focused on the convergence of artificial intelligence and blockchain-based programmable systems. The Company develops software platforms and programmable infrastructure designed to facilitate the tokenization of real-world assets (RWA) and the deployment of Embodied Artificial Intelligence (EAI) in commercial environments. Its mission is to serve as the regulated, programmable infrastructure layer connecting traditional capital markets with on-chain systems and AI-enabled commercial systems.
Show more...
CEO
Jiawei Wang
Employees
10
Country
United States
ISIN
US74754R3012
WKN
000A40THA

Listings

MU
DE
7R9A.MU
STU
DE
7R90.STU
F
DE
7R90.F
MU
DE
7R90.MU

0 Comments

Share your thoughts

FAQ

What is AIxCrypto stock price today?▼
The current price of AIXC is $0.93 USD — it has decreased by -0.57% in the past 24 hours. Watch AIxCrypto stock price performance more closely on the chart.
What is AIxCrypto stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange AIxCrypto stocks are traded under the ticker AIXC.
Is AIxCrypto stock price growing?▼
AIXC stock has fallen by -39.89% compared to the previous week, the month change is a +13.48% rise, over the last year AIxCrypto has showed a -49.67% decrease.
What is AIxCrypto market cap?▼
Today AIxCrypto has the market capitalization of 18.85M
When is the next AIxCrypto earnings date?▼
AIxCrypto is going to release the next earnings report on November 17, 2026.
What is AIxCrypto revenue for the last year?▼
AIxCrypto revenue for the last year amounts to 0 USD.
What is AIxCrypto net income for the last year?▼
AIXC net income for the last year is -19.53M USD.
How many employees does AIxCrypto have?▼
As of August 26, 2026, the company has 10 employees.
In which sector is AIxCrypto located?▼
AIxCrypto operates in the Health & Wellness sector.
When did AIxCrypto complete a stock split?▼
AIxCrypto has not had any recent stock splits.
Where is AIxCrypto headquartered?▼
AIxCrypto is headquartered in EL SEGUNDO, United States.